XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Statements of Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Preferred Stock
Series m Preferred Stock
Preferred Stock
Series m-2 Preferred Stock
Preferred Stock
Series S Preferred Stock
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Additional Paid-in-capital
Accumulative Deficit
Total
Balance as of beginning at Dec. 31, 2022 $ 4,818 $ 480 $ 21,977 $ 1,335 $ 7,173          
Balance as of beginning (in shares) at Dec. 31, 2022 1,855,328 160,000 2,714,732 3,086,160 3,535,621          
Increase (decrease) in temporary equity                    
Share conversion to common stock $ (122)   $ (172) $ (721) $ (75)          
Share conversion to common stock (in shares) (46,830)   (21,232) (1,667,779) (36,762)          
Balance as of end at Mar. 31, 2023 $ 4,696 $ 480 $ 21,805 $ 614 $ 7,098          
Balance as of end (in shares) at Mar. 31, 2023 1,808,498 160,000 2,693,500 1,418,381 3,498,859          
Balance as of beginning at Dec. 31, 2022           $ 28 $ 10 $ 95,716 $ (139,340) $ (43,586)
Balance as of beginning (in shares) at Dec. 31, 2022           28,029,238 10,319,884      
Increase (decrease) in stockholders' equity                    
Stock based compensation               446   446
Conversion of debt obligations to Class A Common Stock           $ 3   4,171   4,174
Conversion of debt obligations to Class A Common Stock (in shares)           2,893,824        
Stock options exercised               225   225
Stock options exercised (in shares)           213,020        
Proceeds from Equity Sale, net of issuance costs           $ 4   4,690   4,694
Proceeds from Equity Sale, net of issuance costs (in shares)           4,424,645        
Share conversion to common stock           $ 2   1,088   1,090
Share conversion to common stock (in shares)           1,753,977 37,938      
Share conversion costs               (4)   (4)
Net Income (Loss)                 (2,444) (2,444)
Balance as of end at Mar. 31, 2023           $ 37 $ 10 106,332 (141,784) $ (35,405)
Balance as of end (in shares) at Mar. 31, 2023           37,314,704 10,357,822      
Balance as of beginning at Dec. 31, 2023 $ 4,621 $ 480 $ 21,390 $ 614 $ 7,098          
Balance as of beginning (in shares) at Dec. 31, 2023 1,779,653 160,000 2,642,190 1,418,381 3,498,859         9,499,083
Increase (decrease) in temporary equity                    
Share conversion to common stock $ (10)   $ (178)              
Share conversion to common stock (in shares) (4,067)   (21,932)              
Balance as of end at Mar. 31, 2024 $ 4,611 $ 480 $ 21,212 $ 614 $ 7,098          
Balance as of end (in shares) at Mar. 31, 2024 1,775,586 160,000 2,620,258 1,418,381 3,498,859         9,473,084
Balance as of beginning at Dec. 31, 2023           $ 80 $ 9 134,735 (161,458) $ (26,634) [1]
Balance as of beginning (in shares) at Dec. 31, 2023           80,188,600 9,357,822      
Increase (decrease) in stockholders' equity                    
Stock based compensation               334   334
Proceeds from Equity Sale, net of issuance costs           $ 14   7,053   7,067
Proceeds from Equity Sale, net of issuance costs (in shares)           13,512,738        
Share conversion to common stock               188   188
Share conversion to common stock (in shares)           46,921        
Share conversion costs               (1)   (1)
Net Income (Loss)                 (7,592) (7,592)
Balance as of end at Mar. 31, 2024           $ 94 $ 9 $ 142,309 $ (169,050) $ (26,638)
Balance as of end (in shares) at Mar. 31, 2024           93,748,259 9,357,822      
[1] The condensed balance sheet as of December 31, 2023 was derived from the audited balance sheet as of that date.